Arthur Feldman | Academic Influence

Arthur Feldman's AcademicInfluence.com Rankings

Arthur Feldman

Computer Science

#5371

World Rank

#5676

Historical Rank

Computational Linguistics

#732

World Rank

#745

Historical Rank

Machine Learning

#1397

World Rank

#1419

Historical Rank

Artificial Intelligence

#1630

World Rank

#1661

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Arthur Feldman's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Arthur Feldman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Arthur Michael Feldman is an American cardiologist and the Laura H. Carnell Professor of Medicine in the Lewis Katz School of Medicine at Temple University, known for his research on heart failure. Among his previous positions include Harry S. Tack Professor and Chief of the Division of Cardiology at the University of Pittsburgh, Magee Chair of the Department of Medicine at Jefferson Medical College, and Executive Dean of the Lewis Katz School of Medicine. He was the founding editor-in-chief of Clinical and Translational Science and the Journal of Clinical and Translational Science. In 2019, he received the Distinguished Scientist Award-Basic Domain from the American College of Cardiology.

(See a Problem?)

Arthur Feldman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. (2004) (5153)
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. (2002) (2786)
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. (2007) (1285)
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) (2004) (1127)
Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST) (2001) (997)
Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. (1997) (875)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
Myocardial viability and survival in ischemic left ventricular dysfunction. (2011) (745)
Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. (1988) (568)
Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy (2001) (524)
The role of tumor necrosis factor in the pathophysiology of heart failure. (2000) (473)
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. (1993) (448)
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. (2000) (432)
Sudden cardiac death in heart failure. The role of abnormal repolarization. (1994) (423)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure (2001) (381)
Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. (1993) (380)
Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. (1998) (377)
Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. (1990) (356)
Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. (2000) (328)
Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. (2000) (327)
Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial (2006) (281)
Age‐Related Changes in β‐Adrenergic Neuroeffector Systems in the Human Heart (1994) (278)
Downregulation of Matrix Metalloproteinases and Reduction in Collagen Damage in the Failing Human Heart After Support With Left Ventricular Assist Devices (2001) (275)
Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. (1997) (266)
Peripartum myocarditis and cardiomyopathy. (1990) (257)
Reduced beta 1 receptor messenger RNA abundance in the failing human heart. (1993) (248)
Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release (2011) (223)
Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. (2005) (222)
Selective Gene Expression in Failing Human Heart: Quantification of Steady‐State Levels of Messenger RNA in Endomyocardial Biopsies Using the Polymerase Chain Reaction (1991) (221)
Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. (1997) (221)
Circulating interleukin-6 in severe heart failure. (1997) (217)
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure (2006) (212)
Intravenous immune globulin in the therapy of peripartum cardiomyopathy. (1999) (210)
Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death: (2004) (208)
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. (2005) (202)
Pharmacogenetic Interactions Between &bgr;-Blocker Therapy and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients With Congestive Heart Failure (2001) (198)
Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. (1992) (190)
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. (2007) (190)
Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. (1997) (172)
The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. (2010) (167)
Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. (1999) (163)
Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure: Results From the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Trial (2009) (160)
Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. (2004) (159)
Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity. (2000) (159)
Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. (2000) (159)
Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction (2006) (149)
TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. (2009) (146)
Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. (2000) (141)
Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. (2002) (137)
Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. (2005) (128)
Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha. (1998) (124)
Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Effect of Aldosterone Antagonism With Eplerenone on Ventricular Remodeling in Patients With Mild-to-Moderate Heart Failure and Left Ventricular Systolic Dysfunction (2010) (124)
Calcium-dependent arrhythmias in transgenic mice with heart failure. (2003) (124)
Tumor Necrosis Factor Receptors 1 and 2 Differentially Regulate Survival, Cardiac Dysfunction, and Remodeling in Transgenic Mice With Tumor Necrosis Factor-&agr;–Induced Cardiomyopathy (2004) (122)
Effect of the Asp298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure (2003) (122)
TNF-&agr; Contributes to Endothelial Dysfunction by Upregulating Arginase in Ischemia/Reperfusion Injury (2007) (122)
Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. (2000) (121)
Overexpression of Tumor Necrosis Factor- α Activates Both Anti- and Pro-Apoptotic Pathways in the Myocardium (2001) (115)
The international EECP patient registry (IEPR): Design, methods, baseline characteristics, and acute results (2001) (113)
Anti–Tumor Necrosis Factor-&agr; Antibody Limits Heart Failure in a Transgenic Model (2001) (106)
Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction (2015) (105)
Effects of Tumor Necrosis Factor Gene Polymorphisms on Patients With Congestive Heart Failure (1998) (104)
Heterogeneous immediate effects of partial left ventriculectomy on cardiac performance. (1998) (104)
Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. (1997) (98)
Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. (2006) (97)
Coxsackievirus B3 Induces T Regulatory Cells, Which Inhibit Cardiomyopathy in Tumor Necrosis Factor-α Transgenic Mice (2006) (95)
Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. (2005) (94)
TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. (2007) (93)
A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women. (2007) (87)
Blockade of NF-κB improves cardiac function and survival without affecting inflammation in TNF-α-induced cardiomyopathy (2005) (87)
Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. (1995) (86)
Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice. (2002) (86)
BAG3: a new player in the heart failure paradigm (2015) (84)
Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Time- and dose-dependence analysis based on pressure-volume relations. (1996) (82)
Feasibility of combined percutaneous transluminal angioplasty and minimally invasive direct coronary artery bypass in patients with multivessel coronary artery disease. (1998) (82)
Altered expression of α-subunits of G proteins in failing human hearts (1989) (81)
Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart. (1998) (81)
Selective versus nonselective beta-blockade for heart failure therapy: are there lessons to be learned from the COMET trial? (2003) (81)
HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America. (2000) (81)
MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. (2002) (80)
Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. (2008) (78)
Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity (2011) (78)
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial. (2009) (78)
Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power. Validation and noninvasive application. (1994) (77)
Pharmacology of hearing and ototoxicity. (1978) (77)
Effects of cholera toxin on cochlear endolymph production: model for endolymphatic hydrops. (1976) (76)
Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure. (2006) (75)
TRPM2 Channels Protect against Cardiac Ischemia-Reperfusion Injury (2014) (74)
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. (2005) (73)
Gi-Biased &bgr;2AR Signaling Links GRK2 Upregulation to Heart Failure (2012) (72)
Myocardial infarction associated with a myocardial bridge. (1986) (71)
Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. (2002) (71)
Endomyocardial gene expression during development of pacing tachycardia-induced heart failure in the dog. (1994) (70)
Mitochondrial Abnormalities in Tumor Necrosis Factor-&agr;–Induced Heart Failure Are Associated With Impaired DNA Repair Activity (2001) (69)
Changes in the receptor-G protein-adenylyl cyclase system in heart failure from various types of heart muscle disease. (1992) (69)
Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. (2004) (69)
Cerebrospinal fluid production: stimulation by cholera toxin. (1977) (68)
Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. (1993) (68)
Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. (2004) (66)
Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. (2000) (65)
Decreased bioactivity of the guanine nucleotide-binding protein that stimulates adenylate cyclase in hearts from cardiomyopathic Syrian hamsters. (1989) (65)
Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. (1995) (64)
Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-α (2003) (63)
Decreased Levels of BAG3 in a Family With a Rare Variant and in Idiopathic Dilated Cardiomyopathy (2014) (62)
The second member of transient receptor potential-melastatin channel family protects hearts from ischemia-reperfusion injury. (2013) (60)
Disruption of Inducible Nitric Oxide Synthase Improves &bgr;-Adrenergic Inotropic Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy (2002) (59)
Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy. (2005) (59)
Evidence for the Role of BAG3 in Mitochondrial Quality Control in Cardiomyocytes (2017) (58)
BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes. (2016) (57)
Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function (2006) (56)
Immunodetectable levels of the inhibitory guanine nucleotide-binding regulatory proteins in failing human heart: discordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. (1991) (56)
Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression. (2001) (55)
Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy. (1991) (55)
Cardioprotection afforded by NF-κB ablation is associated with activation of Akt in mice overexpressing TNF-α (2006) (53)
Ca²⁺ entry via Trpm2 is essential for cardiac myocyte bioenergetics maintenance. (2015) (53)
A1‐Adenosine Receptor Inhibition of Adenylate Cyclase In Failing and Nonfailing Human Ventricular Myocardium (1991) (52)
Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals (2018) (51)
Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3. (2011) (51)
Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+ -K+ -ATPase. (2008) (51)
Classification of positive inotropic agents. (1993) (50)
Induced overexpression of Na+/Ca2+ exchanger transgene: altered myocyte contractility, [Ca2+]i transients, SR Ca2+ contents, and action potential duration. (2009) (50)
Overexpression of tumor necrosis factor- alpha activates both anti- and pro-apoptotic pathways in the myocardium. (1999) (49)
Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registry (IEPR). (2002) (49)
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. (2007) (49)
Chronic exposure to interleukin 1β induces a delayed and reversible alteration in excitation–contraction coupling of cultured cardiomyocytes (2002) (49)
Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha. (2002) (49)
Overexpression of tumor necrosis factor-alpha increases production of hydroxyl radical in murine myocardium. (2003) (48)
Diminished beta-adrenergic receptor responsiveness and cardiac dilation in hearts of myopathic Syrian hamsters (BIO 53.58) are associated with a functional abnormality of the G stimulatory protein. (1990) (48)
Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy. (2005) (47)
Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling. (2011) (47)
Cost of medical services in older patients with heart failure: those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: the Heart Failure Home Care trial. (2010) (46)
Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies (1998) (46)
Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. (2004) (46)
Mechanical cardiac support 2000: current applications and future trial design: June 15-16, 2000 Bethesda, Maryland. (2001) (45)
Experimental issues in assessment of G protein function in cardiac disease. (1991) (44)
Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. (2004) (44)
Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury. (2016) (44)
Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy. (2005) (44)
The beta-adrenergic pathway in the failing human heart: implications for inotropic therapy. (1990) (43)
GRP78 Interacting Partner Bag5 Responds to ER Stress and Protects Cardiomyocytes From ER Stress‐Induced Apoptosis (2016) (42)
Detection of interleukin and interleukin-receptor mRNA in human heart by polymerase chain reaction. (1991) (41)
Arginine vasopressin receptor signaling and functional outcomes in heart failure. (2016) (40)
Adenylyl cyclase: a new target for heart failure therapeutics. (2002) (40)
Benefit and Safety of Enhanced External Counterpulsation in Treating Coronary Artery Disease Patients with a History of Congestive Heart Failure (2001) (40)
Cardiomyocyte contractile impairment in heart failure results from reduced BAG3-mediated sarcomeric protein turnover (2020) (39)
Clinical trials of beta blockers for heart failure (2003) (39)
G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT. (2014) (39)
Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations. (2016) (38)
The beta-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure. (1989) (37)
A1 Adenosine Receptor Upregulation Accompanies Decreasing Myocardial Adenosine Levels in Mice With Left Ventricular Dysfunction (2007) (37)
miR-146a targets Fos expression in human cardiac cells (2015) (36)
Arginine Vasopressin Enhances Cell Survival via a G Protein–Coupled Receptor Kinase 2/β-Arrestin1/Extracellular-Regulated Kinase 1/2–Dependent Pathway in H9c2 Cells (2013) (36)
Regulation of in vivo cardiac contractility by phospholemman: role of Na+/Ca2+ exchange. (2011) (36)
Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts (2007) (35)
Effect of the Asp 298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure (2003) (35)
Myocardial injury after ischemia-reperfusion in mice deficient in Akt2 is associated with increased cardiac macrophage density. (2011) (35)
Differential regulation of cardiac expression of IL-6 and TNF-α by A2- and A3-adenosine receptors. (1999) (35)
Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. (1998) (35)
Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study (2010) (34)
The National Institutes of Health Physician‐Scientist Workforce Working Group Report: A Roadmap for Preserving the Physician‐Scientist (2014) (33)
The Interplay between NF-kappaB and E2F1 Coordinately Regulates Inflammation and Metabolism in Human Cardiac Cells (2011) (33)
The human phospholamban gene: structure and expression. (1999) (32)
The role of tumor necrosis factor alpha in the pathophysiology of congestive heart failure (2000) (32)
Differences in β‐Adrenergic Neuroeffector Mechanisms in Ischemic Versus Idiopathic Dilated Cardiomyopathy (1991) (31)
Up-regulation of beta 2-adrenergic receptors in previously transplanted, denervated nonfailing human hearts. (1993) (31)
Polymorphisms in Adenosine Receptor Genes are Associated with Infarct Size in Patients with Ischemic Cardiomyopathy (2007) (31)
Expression of α-subunits of G proteins in failing human heart : a reappraisal utilizing quantitative polymerase chain reaction (1991) (31)
Treating heart failure with enhanced external counterpulsation (EECP): design of the Prospective Evaluation of EECP in Heart Failure (PEECH) trial. (2005) (30)
Constitutive overexpression of phosphomimetic phospholemman S68E mutant results in arrhythmias, early mortality, and heart failure: potential involvement of Na+/Ca2+ exchanger. (2012) (30)
Haplo‐insufficiency of Bcl2‐associated athanogene 3 in mice results in progressive left ventricular dysfunction, β‐adrenergic insensitivity, and increased apoptosis (2018) (30)
Does Academic Culture Support Translational Research? (2008) (30)
&bgr;-Adrenergic Receptor–Mediated Cardiac Contractility Is Inhibited via Vasopressin Type 1A-Receptor–Dependent Signaling (2014) (30)
Adeno-Associated Virus Serotype 9–Driven Expression of BAG3 Improves Left Ventricular Function in Murine Hearts With Left Ventricular Dysfunction Secondary to a Myocardial Infarction (2016) (29)
Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. (2001) (29)
Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure. (1988) (29)
Cardioprotection afforded by NF-kappaB ablation is associated with activation of Akt in mice overexpressing TNF-alpha. (2006) (29)
Current Landscape of Heart Failure Gene Therapy (2019) (29)
Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Biomarker Substudy of the Surgical Treatment for Ischemic Heart Failure Trials (2013) (28)
Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. (1994) (28)
A common variant alters SCN5A–miR-24 interaction and associates with heart failure mortality (2018) (28)
Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure: a subgroup analysis of the PEECH trial. (2006) (28)
Foundation/American Heart Association Task Force on Practice Guidelines Heart Failure in Adults. A Report of the American College of Cardiology Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of (2009) (28)
HFSA guidelines for the management of patients with heart failure due to left ventricular systolic dysfunction--pharmacological approaches. (2000) (28)
HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy (2017) (27)
AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression. (1999) (27)
Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial. (2007) (26)
Phospholemman and beta-adrenergic stimulation in the heart. (2010) (26)
Teaching Medical Professionalism In The AMC (2009) (25)
Enhanced external counterpulsation: Mechanism of action (2002) (25)
Rationale and design of the enoximone clinical trials program. (2005) (25)
The balance between pro-apoptotic and anti-apoptotic pathways in the failing myocardium (2007) (25)
Pharmacologic Therapy of Chronic Heart Failure (2007) (25)
Cardiac‐Restricted Overexpression of the A2A‐Adenosine Receptor in FVB Mice Transiently Increases Contractile Performance and Rescues the Heart Failure Phenotype in Mice Overexpressing the A1‐Adenosine Receptor (2008) (24)
G&bgr;&ggr;-Independent Recruitment of G-Protein Coupled Receptor Kinase 2 Drives Tumor Necrosis Factor &agr;–Induced Cardiac &bgr;-Adrenergic Receptor Dysfunction (2013) (24)
Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. (2003) (24)
Dysregulation of mitochondrial bioenergetics and quality control by HIV‐1 Tat in cardiomyocytes (2018) (23)
Is There Any Future for Tumor Necrosis Factor Antagonists in Chronic Heart Failure? (2004) (22)
The Multifunctional Protein BAG3 (2018) (22)
Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. (2014) (22)
Safety of iodinated intravenous contrast medium administration in sickle cell disease. (2012) (22)
End-systolic pressure-dimension relationship of in situ mouse left ventricle. (1998) (22)
Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease (2002) (22)
Congestive cardiomyopathy in patients on continuous ambulatory peritoneal dialysis. (1988) (22)
Bench‐to‐Bedside; Clinical and Translational Research; Personalized Medicine; Precision Medicine—What's in a Name? (2015) (21)
Developing Strategies to Link Basic Cardiovascular Sciences with Clinical Drug Development: Another Opportunity for Translational Sciences (2007) (21)
Unstable angina: Specialty‐related disparities in implementation of practice guidelines (1998) (21)
Coordinated regulation of cardiac Na(+)/Ca (2+) exchanger and Na (+)-K (+)-ATPase by phospholemman (FXYD1). (2013) (20)
Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial. (2001) (20)
Paroxetine‐mediated GRK2 Inhibition Reverses Cardiac Dysfunction and Remodeling Post‐Myocardial Infarction (2015) (20)
IL-1 beta alters the expression of the receptor tyrosine kinase gene r-EphA3 in neonatal rat cardiomyocytes. (1998) (19)
Cardioprotection of Controlled and Cardiac-Specific Over-Expression of A2A-Adenosine Receptor in the Pressure Overload (2012) (19)
Matrix Metalloproteinases in the Progression of Heart Failure (2012) (19)
Altered expression of alpha-subunits of G proteins in failing human hearts. (1989) (19)
NAD+-mediated stimulation of adenylate cyclase in cardiac membranes. (1987) (18)
Induced overexpression of Na(+)/Ca(2+) exchanger does not aggravate myocardial dysfunction induced by transverse aortic constriction. (2013) (18)
Increased vasopressin 1A receptor expression in failing human hearts. (2014) (18)
Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease. (2021) (17)
Measurement of the hydrostatic pressures of the cochlear compartments. (1979) (17)
Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors. (1999) (17)
Cardiac Dysfunction in HIV‐1 Transgenic Mouse: Role of Stress and BAG3 (2015) (17)
The pharmacokinetics of etanercept in patients with heart failure. (2001) (17)
Modified inferior vena caval anastomosis to reduce tricuspid valve regurgitation after heart transplantation. (2007) (16)
Role of Cyclic AMP in Cerebrospinal Fluid Production (1980) (16)
Regulation of L-type calcium channel by phospholemman in cardiac myocytes. (2015) (16)
Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial. (2016) (15)
The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials? (2003) (15)
New insight into the role of enhanced adrenergic receptor-effector coupling in the heart. (1999) (15)
Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy. (1996) (15)
Phospholemman and -adrenergic stimulation in the heart (2010) (15)
Role of Bcl2-associated Athanogene 3 in Turnover of Gap Junction Protein, Connexin 43, in Neonatal Cardiomyocytes (2019) (14)
Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression. (2012) (14)
Effects of indomethacin on cholera toxin-induced cerebrospinal fluid production (1978) (13)
Effects of cardiac-restricted overexpression of the A(2A) adenosine receptor on adriamycin-induced cardiotoxicity. (2010) (13)
TNF- a reduces PGC-1 a expression through NF- k B and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model (2009) (13)
Negative Inotropic Effects of Furosemide in the Isolated Rabbit Heart: A Prostaglandin‐Mediated Event (1987) (13)
Mitochondrial dysfunction in human immunodeficiency virus‐1 transgenic mouse cardiac myocytes (2018) (13)
Phorbol ester-induced inhibition of the beta-adrenergic system in pulmonary endothelium: role of a pertussis toxin-sensitive protein. (1989) (13)
Myocardial Fas and Cytokine Expression in End‐Stage Heart Failure: Impact of LVAD Support (2008) (13)
Oculostenotic reflex and iatrogenosis fulminans. (2000) (13)
Assessment of infarct size and myocardial function in mice using transesophageal echocardiography. (2004) (12)
Characterization of proximal transcription regulatory elements in the rat phospholamban promoter. (1999) (12)
Can we alter survival in patients with congestive heart failure? (1992) (12)
The Physician–Hospital Team: A Successful Approach To Improving Care in a Large Academic Medical Center (2006) (12)
American medical education at a crossroads (2015) (12)
Erratum: Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism (Proceedings of the National Academy of Sciences of the USA (June 15, 1992) 89:12 (5251-5255)) (1992) (12)
Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure) (2017) (12)
Neprilysin Inhibition in the Time of Precision Medicine. (2016) (11)
Identification of Candidate Long Noncoding RNAs Associated with Left Ventricular Hypertrophy (2015) (11)
Effect of cholera toxin and prostaglandins on the rat choroid plexus in vitro (1979) (11)
Transcatheter aortic valve replacement: flattening the cost curve. (2014) (11)
Predicting short-term outcome in severely ill heart failure patients: implications regarding listing for urgent cardiac transplantation and patient selection for temporary ventricular assist device support. (1998) (11)
CTS: A New Discipline to Catalyze the Transfer of Information (2008) (11)
Differential effects of overexpression of two forms of ephrin-A5 on neonatal rat cardiomyocytes. (2001) (11)
Genetic Testing for Inherited Cardiac Diseases in Underserved Populations of Non-European Ancestry: Double Disparity (2018) (11)
-Independent Recruitment of G-Protein Coupled Receptor Kinase 2 Drives Tumor Necrosis Factor α –Induced Cardiac β -Adrenergic Receptor Dysfunction (2013) (11)
Heart Failure Society of America: heart failure awareness. (2000) (11)
Adenosine receptor subtypes and the heart failure phenotype: translating lessons from mice to man. (2011) (11)
Effects of chronic ethanol exposure on cardiac receptor-adenylyl cyclase coupling: studies in cultured embryonic chick myocytes and ethanol fed rats. (1991) (11)
Trpm2 enhances physiological bioenergetics and protects against pathological oxidative cardiac injury: Role of Pyk2 phosphorylation (2019) (10)
Human cardiac sodium channels expressed in Xenopus oocytes. (1990) (10)
Enhanced external counterpulsation is a safe and effective treatment for angina in patients with severe left ventricular dysfunction (1999) (10)
The p65 subunit of NF-kB binds to PGC-1a, linking inflammation and metabolic disturbances in cardiac cells (2010) (10)
17β-Estradiol Improves Survival in Male Mice with Cardiomyopathy Induced by Cardiac-Specific Tumor Necrosis Factor-α Overexpression (2005) (10)
The COMET trial. (2005) (10)
Definition, classification, and staging of the adult cardiomyopathies: a proposal for revision. (2004) (10)
Regulated Overexpression of the A 1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function (2006) (9)
TNF alpha—Still a Therapeutic Target (2008) (9)
Lives in Translation (2010) (9)
Heart Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human (1998) (9)
A 1 Adenosine Receptor Upregulation Accompanies Decreasing Myocardial Adenosine Levels in Mice With Left Ventricular Dysfunction failure, transgenic mice with left ventricular systolic Molecular Cardiology (2007) (8)
Academic cardiology division in the era of managed care. A paradigm for survival. (1997) (8)
Decreased adenylate cyclase activity and expression of Gs alpha in human myocardium after orthotopic cardiac transplantation. (1995) (8)
The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy. (2021) (8)
Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy. (2009) (8)
The emerging role of pharmacogenomics in the treatment of patients with heart failure. (2003) (7)
Pharmacogenetics in heart failure: how it will shape the future. (2010) (7)
Lamin B is a target for selective nuclear PQC by BAG3: implication for nuclear envelopathies (2019) (7)
A Metric‐Based System for Evaluating the Productivity of Preclinical Faculty at an Academic Medical Center in the Era of Clinical and Translational Science (2015) (7)
Vasopressin Antagonists for Patients With Acute Heart Failure: Interpreting New Clinical and Translational Data (2014) (7)
Understanding Health Care Reform: Bridging the Gap Between Myth and Reality (2011) (7)
Precision Medicine for Heart Failure: Lessons From Oncology. (2017) (7)
Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion. (2014) (7)
Effects of enhanced external counterpulsation on internal mammary artery flow: comparison with intrasortic balloon counterpulsation (1998) (7)
Mr40,000 and Mr 39,000 Pertussis Toxin Substrates Are Increased in Surgically Denervated Dog Ventricular Myocardium (1991) (6)
Teasing the Immune System to Repair the Heart. (2020) (6)
Advocacy: A New Arena for the Translational Scientist (2011) (6)
VESNARINONE FOR HEART FAILURE. AUTHORS' REPLY (1994) (6)
17 Beta-estradiol improves survival in male mice with cardiomyopathy induced by cardiac-specific tumor necrosis factor-alpha overexpression. (2005) (6)
UV light synergistically enhances the cardiotoxic effects of interleukin 1beta through peroxynitrite formation. (2001) (6)
Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction. (2016) (6)
Involvement of Inducible Nitric Oxide Synthase in (2002) (6)
Incorporating Clinical and Translational Science into the Undergraduate Medical Education Curriculum (2015) (6)
Efficacy and safety of enhanced external counterpulsation in mild to moderate heart failure: A preliminary report (1999) (6)
Whole transcriptome microarrays identify long non-coding RNAs associated with cardiac hypertrophy (2015) (6)
The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta‐analysis of COMPANION and CARE‐HF (2022) (5)
Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial (2017) (5)
Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group. (1999) (5)
Adenoviral-directed overexpression of soluble tumor necrosis factor receptors reverses myocarditis in transgenic mice with congestive heart failure (1998) (5)
Pharmacologic Properties and Clinical Evaluation of the New Inotropic Agent OPC‐8212 (Vesnarinone) (1993) (5)
Relationship of inferior vena cava filter usage in post-surgical patients by various surgical and medical subspecialists. (2008) (5)
Heart Failure: Pharmacologic Management (2006) (5)
Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT. (2019) (5)
Expression of alpha-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction. (1991) (5)
Pharmacodynamics and tolerance of oral sustained release ritodrine. (1988) (5)
Overexpression of tumor necrosis factor-α activates the expression of multiple members of the apoptosis pathway in transgenic mice (1998) (5)
Evidence for the impact of BAG3 on electrophysiological activity of primary culture of neonatal cardiomyocytes (2019) (4)
Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials (2015) (4)
Pursuing Excellence in Healthcare: Preserving America's Academic Medical Centers (2009) (4)
Quinolinone derivatives in the management of congestive heart failure. (1994) (4)
Novel BAG3 Variants in African American Patients with Cardiomyopathy: Reduced β-Adrenergic Responsiveness in Excitation-Contraction. (2020) (4)
New therapeutic option for patients with time-dependent risk of sudden cardiac arrest: application of novel wearable cardioverter-defibrillator (2002) (4)
To Breastfeed or Not to Breastfeed With Peripartum Cardiomyopathy∗ (2019) (4)
Heart transplantation: the Johns Hopkins Hospital experience. (1987) (4)
Role of immune globulin in the treatment of postpartum cardiomyopathy (1998) (3)
Clinical Characteristics of Vesnarinone (2004) (3)
Combination lapatinib and capecitabine in advanced, incurable squamous cell carcinoma of the head and neck (SCCHN). (2013) (3)
Differences in /3-Adrenergic Neuroeffector Mechanisms in Ischemic Versus Idiopathic Dilated Cardiomyopathy (2005) (3)
The Changing Demographics Of America’s Amcs (2009) (3)
Re‐envisioning Our Approach to Research in Academia (2008) (3)
From clinical trials to clinical practice: what we know and do not know about beta-blockers and the heart. (2000) (3)
An observational pre-post study of re-structuring Medicine inpatient teaching service: Improved continuity of care within constraint of 2011 duty hours. (2015) (3)
Commentary: Preparing Internists for the 21st Century (2011) (3)
Multiple effects of ethanol on cardiac adenylate cyclase. (1989) (3)
Commentary: Advancing the Research Mission in an Academic Department: The Creation of a Center for Translational Medicine (2010) (3)
The Heart Failure Society of America in 2020: a vision for the future. (2012) (3)
Mortgaging the Future of Medical Research (2012) (3)
The Bayh‐Dole Act, A Lion without Claws (2015) (3)
In the Jungle (2010) (3)
Health Care Reform and Translational Medicine (2010) (3)
Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients With Advanced Heart Failure (2009) (2)
β2adrenergic receptor variant lle164: effect on heart failure survival and impact of beta blockade (2002) (2)
Matrix Metalloproteinases and Myocardial Remodeling in Heart Failure (2003) (2)
Regulating cardiac cytokine expression: the role of the adrenergic nervous system. (2000) (2)
Integrated coronary revascularization—minimally invasive coronary bypass combined with angioplasty: initial experience in 25 patients (1998) (2)
Solving One of Graduate Medical Education's Problems: A Loss of Thoroughness. (2017) (2)
Working group 1: How to increase the output of cardiologists. (2004) (2)
Ivabradine in Cardiovascular Disease: Heart Rate Isn't Everything (2015) (2)
On being a chair of medicine in 2012. (2012) (2)
Translational Research and the Health Insurance Industry (2009) (2)
Publishing “Invisible” and “Abandoned” Clinical Trials: A Commitment for CTS (2013) (2)
Letter by Feldman et al Regarding Article, "Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery". (2019) (2)
The role of endomyocardial biopsy in the management scientific statement of the ESC (european society of cardiology) (2007) (2)
Force on Practice Guidelines, International Society for Heart and Lung American College of Cardiology Foundation/American Heart Association Task Diagnosis and Management of Heart Failure in Adults 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the (2009) (2)
Heart failure awareness. (1999) (2)
The development of β-adrenergic receptor antagonists for the treatment of heart failure: a paradigm for translational science. (2011) (2)
Abstract 2375: Regulation of Cardiac Myocyte Contractility by Phospholemman (2008) (2)
Time for Change (2009) (2)
ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults (2009) (2)
The Clinical and Translational Science “Tent” (2010) (2)
Isosorbide Dinitrate and Hydralazine as Therapy for African Americans with Heart Failure; a Failed Paradigm? (2009) (2)
The dying patient. (1987) (2)
Protecting the integrity of clinical trial results in the digital age. (2005) (1)
Cardiac Transduction in Mini-Pigs After Low-Dose Retrograde Coronary Sinus Infusion of AAV9-BAG3 (2022) (1)
Role of Bcl2-associated Athanogene 3 in Turnover of Gap Junction Protein, Connexin 43, in Neonatal Cardiomyocytes (2019) (1)
Heart failure : device management (2010) (1)
Cardiac Resynchronization Therapy (2009) (1)
Commercial Clinical Genetic Sequencing Panels for Evaluating Patients with Familial Disease—Are They Ready for Prime Time? (2013) (1)
Introduction: there is an important need for increased understanding of the pathophysiology of heart failure postinfarction, new treatment strategies, earlier implementation of effective strategies, and more effective use of existing therapies. (2006) (1)
P5-103: The significance of ICD shocks in CRT treated patients in the COMPANION Trial on major outcomes (2006) (1)
Abstract 3861: Over-expression of the A1-Adenosine Receptor Alters Cardiac Function by Inhibiting Production of Caveolin-3 (2009) (1)
Precision Medicine for Heart Failure: Back to the Future. (2019) (1)
Editorial: Medical Education in the United States: Are We Building a Multitiered System? (2010) (1)
Oral milrinone in severe chronic heart failure. (1992) (1)
Bag3 Regulates Mitochondrial Function and the Inflammasome Through Canonical and Noncanonical Pathways in the Heart (2023) (1)
Abstract 18566: V1A Receptor Overexpression in the Murine Heart Depresses the Inotropic Response to Catecholamines (2013) (1)
Polygenic risk assessment improves usefulness of genotyping in heart failure populations: additive effects of ACE and eNOS polymorphisms (2002) (1)
FINAL ACCEPTED VERSION Cardioprotection Afforded by NF-B Ablation Is Associated with Activation of Akt In Mice Over-Expressing TNF Running head: Akt and NF-B activity in TNF-induced heart failure (2005) (1)
Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies (2022) (1)
Images in Cardiovascular Medicine Oculostenotic Reflex and Iatrogenosis Fulminans (2000) (1)
G i -Biased (cid:1) 2 AR Signaling Links GRK2 Upregulation to Heart Failure (2012) (1)
cDNA sequence for the α subunit of the guanine nucleotide-binding protein that stimulates adenylyl cyclase (Gsα) in Syrian hamster heart (Mesocricetus auratus) (1990) (1)
Will We Ever See Tort Reform in the United States (2011) (1)
The Municipal Safety Net Hospital: A Concept Whose Time Has Come Again? (2011) (1)
Restructuring the academic department of internal medicine. (2005) (1)
P63Long non-coding RNAs and cardiac hypertrophy (2014) (1)
Clinical and Translational Science (CTS): 2005–2015 (2015) (1)
Publishing Genomic Studies: Walking the Fine Line (2012) (1)
The effect of cholera toxin on choroid plexus carbonic anhydrase activity in vitro. (1980) (1)
Academic Medical Centers: Too Big to Fail (2013) (1)
Cardiac resynchronization therapy: from creation to evolution--an evidence-based review. (2007) (1)
Restoring public trust in scientific research by reducing conflicts of interest. (2019) (1)
Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy. (2019) (1)
G Independent Recruitment of G-Protein Coupled Receptor Kinase 2 Drives TNF -Induced Cardiac Beta-Adrenergic Receptor Dysfunction (2013) (1)
Undergraduate medical education in the U.S. and Israel: contrasts and common challenges (2015) (1)
BAG3-dependent autophagy maintains sarcomere function in cardiomyocytes (2020) (1)
FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART (2009) (1)
New therapeutic agents for the management of congestive heart failure. (1994) (1)
Understanding health care reform (2015) (0)
Precision Medicine (2023) (0)
Winning the war on cancer. (1997) (0)
Abstract 15374: Interaction of G-Protein Beta 3 Subunit (GNB3) and G-Protein Receptor Kinase 5 (GRK5) Genotypes Impacts Heart Failure Outcomes in African Americans (2017) (0)
Inotropic agents and adrenergic agonists as therapy for congestive heart failure (1991) (0)
Technology Burden Alters Hospital Quality and Cost (2016) (0)
Detectable troponin T level predicts high mortality in patients with heart failure undergoing internal defibrillator implantation (2002) (0)
PULSATILE VS CONTINUOUS FLOW LVAD: THE ALDOSTERONE RESPONSE & MYOCARDIAL REMODELING (2002) (0)
Abstract MP101: Functional Maintenance of the Sarcomere Requires Bag3-dependent Autophagy (2020) (0)
TRPM2ChannelsProtectagainstCardiacIschemia-Reperfusion InjuryIA *□S (2014) (0)
Abstract 2696: Phospholemman and B-Adrenergic Stimulation in Intact Hearts (2009) (0)
Resolving The Physician Workforce Crisis (2009) (0)
D003 Angiogenic effects of adenosine involve regulation of vascular endothelial growth factor and soluble vascular endothelial growth factor receptor -1 (2009) (0)
Welcome to your Journal of Clinical and Translational Science (2017) (0)
Heart Failure as a National Health Problem: The Burden of Heart Failure (2007) (0)
AHEART June 45/6 (1999) (0)
SUPPLEMENTAL MATERIAL Controlled and Cardiac-Restricted Overexpression of the Arginine Vasopressin V 1 A Receptor Causes Reversible Left Ventricular Dysfunction Through G q-Mediated Cell Signaling (2011) (0)
OJ-148 Expression of Protein S, a Vitamin K-dependent Glycoprotein, is Up-regulated in the Murine Heart with TNF-α Induced Cardiomyopathy(OJ25,Myocarditis, Basic/ Clinical (M),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society) (2009) (0)
Abstract 3396: Controlled Over-expression of A2A -R Provides Protection From Pressure Induced Cardiac Failure Through Down Regulation of GATA-4 (2009) (0)
Precision Medicine for Heart Failure (2019) (0)
A Shocking Turn of Events. (2018) (0)
cDNA sequence for the alpha subunit of the guanine nucleotide-binding protein that stimulates adenylyl cyclase (Gs alpha) in Syrian hamster heart (Mesocricetus auratus). (1990) (0)
The Effect of 3,3′,5-Triiodo-l-Thyronine on the Renal Handling of Citrate (1975) (0)
Comprar Heart Failure: Device Management | Eric Carlson | 9781405152587 | Wiley (2009) (0)
TNF.-Induced Cardiac Beta-Adrenergic Receptor Dysfunction (2016) (0)
G-PROTEIN RECEPTOR KINASE 5 POLYMORPHISMS AND OUTCOMES IN THE AFRICAN AMERICAN HEART FAILURE TRIAL: RESULTS FROM THE GENETIC RISK ASSESSMENT OF HEART FAILURE IN AFRICAN-AMERICANS SUB-STUDY (2017) (0)
Forging a Stronger Bond between SCTS and CTS (2011) (0)
Molecular regulation of signal transduction proteins in heart failure (1991) (0)
The Global Financial Crisis: (2009) (0)
Same-Day Discharge After Percutaneous Coronary Intervention Trial Sequential of (2014) (0)
The Heart Failure Home Care (HFHC) Trial : A Multicenter, Randomized, Controlled Trial of a Computer Based Telephonic Heart Failure Monitoring System: Design and Methods (2003) (0)
Optimal intravenous inotropic therapy in severe congestive heart failure (1998) (0)
Strategies for pharmacologic modulation of the heart failure phenotype–Modulating the heart failure phenotype (1995) (0)
With Chronic Heart Failure Enhanced External Counterpulsation Improves Exercise Tolerance in Patients (2006) (0)
Prospective evaluation of EECP in congestive hearth failure (2006) (0)
Will There Be Enough Doctors to Care for 35 Million New Patients (2011) (0)
Role of Disease Prevention in Health Care Reform (2011) (0)
Can Research Guide Us to Improved Care at Lower Costs (2011) (0)
Integrating The Diverse Structures Of Academic Medical Centers (2009) (0)
Pharmacogenomics of Heart Failure(State-of-the-Art, New Approaches to Heart Failure-from Pharmacogenomics to Drug Development, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Daniel R Wagner: An appreciation. (2017) (0)
Abstract 909: Determining the Role of the Co-chaperone BAG3 at the Cardiac Myofilament (2019) (0)
Abstract 17953: GrBeta Gammar Independent Recruitment Of G-protein Coupled Receptor Kinase 2 Drives TNF Alpha-induced Cardiac Beta-adrenergic Receptor Dysfunction (2012) (0)
An Opportunity to Definitively Evaluate the Theoretical Risks of Neprilysin Inhibition. (2017) (0)
Adenosine Inhibits Lipopolysaccharide-Induced Cardiac Expression of Tumor Necrosis Factor- (cid:97) (1998) (0)
Management of Diastolic Dysfunction (2007) (0)
ldosterone Synthase Promoter olymorphism Predicts Outcome in frican Americans With Heart Failure esults From the A-HeFT Trial (2006) (0)
Conflict of Interest Table) (2010) (0)
Resolving Conflicts Of Interest (2009) (0)
to Reduce Tricuspid Valve Regurgitation after Heart Transplantation (2007) (0)
Conclusion: Finding the Right Device or the Right Patient (2010) (0)
Leadership In The Academic Medical Center (2009) (0)
The human phospholamban gene: Expression and structure (1998) (0)
Heart failure : pharmacological management (2006) (0)
Come 1 CHAPTER 1 Cardiac Resynchronization Therapy (2009) (0)
Evidence of phenotypic alteration as a cause of systolic dysfunction in the failing heart. (1998) (0)
Reforming the Private Insurance Industry (2011) (0)
Oliver Elon Owen, MD: 1934–2010 (2012) (0)
Use of devices with both cardiac resynchronization and cardioverter–defibrillator capabilities (2007) (0)
Strain-Specific Patterns of Cardiac Rhythm, Autonomic Nervous System Activity, and Susceptibility to Heart Failure in Mice (2002) (0)
Abstract 4855: Influence of Left Ventricular End Diastolic Diameter Index on Clinical Outcomes with Cardiac Resynchronization: Insights from the COMPANION Study (2008) (0)
Sailing From Bench to Bedside (2009) (0)
Developing Strategic Regional And Global Collaborations (2009) (0)
Financing The Missions Of The AMC (2009) (0)
The Heart-Brain Continuum: A New Way of Looking at Heart Failure Therapy. (2018) (0)
A 008 PRESENCE OF TISSUE FACTOR AND OTHER COMPONENTS OF ATHEROSCLEROSIS IN HUMAN AORTIC VALVE STENOSIS (2009) (0)
New Innovations in the Treatment of Heart Failure(Keynote Lecture, Clinical Heart Failure-Pathophysiology and Treatment, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Book Review Congestive Cardiac Failure: Pathophysiology and Treatment Edited by David B. Barnett, Hubert Pouleur, and Gary S. Francis. 383 pp. New York, Marcel Dekker, 1993. $135. 0-8247-8821-4 (1994) (0)
HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy (2017) (0)
How Will Health Care Reform Affect the Medically Underserved and the Safety Net Hospitals That Care for Them (2011) (0)
Lamin B is a target for selective nuclear PQC by BAG3: implication for nuclear envelopathies (2019) (0)
β-Adrenergic Receptor Dysfunction in the Pathogenesis of Idiopathic Dilated Cardiomyopathy (1993) (0)
Positive inotropic effects of vesnarinone in severe heart failure: Results of the VEST ventricular function substudy (1998) (0)
Abstract 1528: Phospholemman Regulates Cardiac Na+/Ca2+ Exchanger: Interaction with Residues 238-270 and 300-328 of the Intracellular Loop (2008) (0)
Federal Politics and the Clinical and Translational Sciences (2011) (0)
172 - Multicenter GRAHF2 Investigation (Genomic Response Analysis of Enhanced Heart Failure Therapy in African Americans): Objectives, Study Design and Initial 100 Subjects (2017) (0)
How Can We Improve the Quality of Care in the United States (2011) (0)
Book Review Molecular Mechanisms of Cardiac Hypertrophy and Failure Edited by Richard A. Walsh. 736 pp., illustrated. Abingdon, England, Informa Healthcare/Taylor & Francis, 2005. $749.95. 1-84214-248-8 (2006) (0)
TRPM2 Channels Protect Hearts from Ischemia-Reperfusion Injury (2013) (0)
Educating CTS Trainees (2010) (0)
Functional and Metabolic Consequences of Vitamin B-6 Deficiency in the Rat Heart (1987) (0)
Review Article Influence of Diabetes on Cardiac Resynchronization Therapy With or Without Defibrillator in Patients With Advanced Heart Failure (2007) (0)
Can We Lower Health Care Costs by Eliminating Waste (2011) (0)
Abstract 3581: The Influence of Diabetes on Outcome with Cardiac Resynchronization Therapy: Results from the COMPANION Trial (2006) (0)
Scientific Publishing in the Electronic Age (2011) (0)
It's Not Time To Needle in Acute Decompensated Heart Failure (2006) (0)
Ensuring Governmental Support And Oversight Of The AMC (2009) (0)
Commercializing Research Discoveries (2009) (0)
Integrating Clinical Care Delivery Systems (2009) (0)
Abstract 1893: Is Early Symptomatic Improvement Associated with Long-term Benefit with Cardiac Resynchronization? Insights from the COMPANION Study (2007) (0)
Abstract 16634: Bcl2 Associated Athanogene 3 Haplo-insufficiency Decreases Cardiac Function and Attenuates Response to Stress (2017) (0)
Reduced flB Receptor Messenger RNA Abundance in the Failing Human Heart Heart (0)
Comprar Prebiotics and Probiotics | Arthur Feldman | 9781905224524 | Wiley (2009) (0)
Unregulation and persistent activation of c-Jun NH2-terminal kinases in the ischemic failing human heart (1998) (0)
Selective GeneExpression inFailing HumanHeart Quantification ofSteady-State Levels ofMessenger RNA inEndomyocardial Biopsies Usingthe Polymerase ChainReaction (1991) (0)
Abstract 15965: BAG3 Rescues Contractile Dysfunction Post-MI: Cellular Mechanism (2016) (0)
Creating Gender Equity in the Clinical and Translational Sciences (2012) (0)
Abstract 3673: A Novel Mechanism for Akt2 in Ischemic Myocardial Repair: Limiting Macrophage Density (2009) (0)
Alterations of the β‐adrenergic signaling pathway in cardiac failure and its role in pathophysiology and treatment (1992) (0)
Failing Human Ventricular Myocardium (2005) (0)
Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy-Adrenergic Inotropic β Disruption of Inducible Nitric Oxide Synthase Improves (2002) (0)
Mixing Politics and Medicine: A Case Study (2014) (0)
Performance Metrics for an Academic Society—The Annual Meeting (2011) (0)
Abstract 17218: ATP Binding to Akt Kinases Confer Dephosphorylation Resistence in Caveolin 3/ Membrane Rafts (2011) (0)
nhanced External ounterpulsation Improves Exercise olerance in Patients With Chronic Heart Failure (2006) (0)
BAG3: Nature’s Quintessential Multi-Functional Protein Functions as a Ubiquitous Intra-Cellular Glue (2023) (0)
Adenosine inhibits immediate cardiodepressive effects of tumor necrosis factor-alpha in adult cardiomyocytes (1998) (0)
Abstract 1600: Cardiac Resynchronization Therapy Reduces the Risk of Hospitalizations in Patients with Advanced Heart Failure - Results From the COMPANION Trial (2007) (0)
Pharmacogenetic Interactions Between b -Blocker Therapy and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients With Congestive Heart Failure in a population of patients with (2001) (0)
Bring Business Lessons to CTS (2009) (0)
Experimental Heart Failure Models of Cytokine Overexpression (2001) (0)
Differential effects of exogenous and endogenous adenosine on myocardial proinflammatory cytokine gene expression (1998) (0)
myocytes pump activity in postinfarction + decreased Na -ATPase in adult rat cardiac myocytes: relevance to + -K + Phospholemman overexpression inhibits Na (2015) (0)
Basic Science and Experimental Study Induced Overexpression of Na D /Ca 2D Exchanger Does Not Aggravate Myocardial Dysfunction Induced by Transverse Aortic Constriction (2012) (0)
Regulation of Gene Expression in the Failing Myocardium: Evidence for a Heart Failure Gene Program (1994) (0)
766-2 In Vivo Measurement of Myocardial Gene Expression in the Human Heart (1995) (0)
Explant Myocarditis: Evidence for the Role of Inflammation in Decompensation of Advanced Heart Failure Patients (1998) (0)
Abstract 3862: Controlled Overexpression of Na+/Ca2+ Exchanger Does Not Lead to Heart Failure (2009) (0)
With Congestive Heart Failure Variant of Endothelial Nitric Oxide Synthase on Survival for Patients 298 Effect of the Asp (2003) (0)
How Will Health Care Reform Change the Way We Practice Medicine (2011) (0)
Angiotensin Converting Enzyme Deletion Polymorphism Does Not Increase the Risk of Heart Failure (1998) (0)
The Human Factor (2006) (0)
Ca 2 (cid:2) entry via Trpm2 is essential for cardiac myocyte bioenergetics maintenance MAMMALIAN CELLS (2015) (0)
Voltage dependent sodium channels from human cardiac rna expressed in xenopus oocytes (1988) (0)
Chapter 42 – Pharmacogenomics and Pharmacogenetics in Heart Failure (2011) (0)
Abstract 878: Wild Type A1 Adenosine Receptor and a Mutated A1 Adenosine Receptor Differentially Induced Cardiomyopathy Gene Expression In Transgenic Mouse Hearts (2006) (0)
A010 Interference with Toll-Like Receptor 4 pathway mediates the anti-inflammatory effects of adenosine (2009) (0)
Adenosine inhibits cardiac expression of tumor necrosis factor-alpha in the failing human heart (1998) (0)
Multinational Trials: Lost in Translation? (2009) (0)
How Will Health Care Reform Affect the Medicare and Medicaid Populations (2011) (0)
MIR-146A is a novel negative regulator of cfos gene expression in human cardiac cells (2014) (0)
GENOMIC SCORE TO TARGET THERAPY WITH A FIXED DOSE COMBINATION OF HYDRALAZINE AND ISOSORBIDE DINITRATE (2016) (0)
Hyperthermia and cancer research. (1984) (0)
Fixing The “Broken Pipeline” Of AMC Scientists (2009) (0)
Comprar Pacing to Support the Failing Heart | Arthur M. Feldman | 9781405175340 | Wiley (2009) (0)

This paper list is powered by the following services:

Other Resources About Arthur Feldman

en.wikipedia.org

What Schools Are Affiliated With Arthur Feldman?

Arthur Feldman is affiliated with the following schools: